Utilizing a novel model of PANoptosis-related genes for enhanced prognosis and immune status prediction in kidney renal clear cell carcinoma
2024 · APOPTOSIS · 27 citations
https://doi.org/10.1007/s10495-023-01932-3
Z
Zhansheng Jiang
Tianjin Medical University Cancer Institute and Hospital(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
71
Papers
1.0K
Citations
18
h-index
30
i10-index
Zhansheng Jiang is an academic researcher from Tianjin Medical University Cancer Institute and Hospital. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Ferroptosis and cancer prognosis & Lung Cancer Research Studies. The author has an h-index of 18, co-authored 61 publications.
ORCID: 0000-0002-5707-5148Papers by this author
worksOptimal therapy for concomitant EGFR and TP53 mutated non-small cell lung cancer: a real-world study
2023 · BMC Cancer · 22 citations
https://doi.org/10.1186/s12885-023-10637-4
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study
2022 · European Journal of Cancer · 20 citations
https://doi.org/10.1016/j.ejca.2022.06.059
Baicalin reverses radioresistance in nasopharyngeal carcinoma by downregulating autophagy
2020 · Cancer Cell International · 18 citations
https://doi.org/10.1186/s12935-020-1107-4
Identification and analysis of microplastics in peritumoral and tumor tissues of colorectal cancer
2025 · Scientific Reports · 15 citations
https://doi.org/10.1038/s41598-025-98268-6
Expert consensus on the diagnosis and treatment of <scp>RET</scp> gene fusion <scp>non‐small</scp> cell lung cancer in <scp>China</scp>
2023 · Thoracic Cancer · 12 citations
https://doi.org/10.1111/1759-7714.15105
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat